All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Newron Pharmaceuticals S.p.A. ratings

Newron Pharmaceuticals S.p.A. stock ratings worldwide, in Switzerland and on EBS stock exchange.
Add to widgets
Added to widgets

Newron Pharmaceuticals S.p.A. ratings on EBS

Newron Pharmaceuticals S.p.A. ratings are monitored online at allstockstoday.com Newron Pharmaceuticals S.p.A. ratings are collected from verified information channels. Each rating has its own meaning and meaning. View Newron Pharmaceuticals S.p.A. ratings online for free.

Show:
to

Newron Pharmaceuticals S.p.A. is #126 in rating Stock price grown in a week on EBS. Newron Pharmaceuticals S.p.A. is #144 in rating Stock price grown in a month on EBS. Newron Pharmaceuticals S.p.A. is #151 in rating Stock price grown in 3 months on EBS. Newron Pharmaceuticals S.p.A. is #152 in rating Stock price grown in a year on EBS. Newron Pharmaceuticals S.p.A. is #154 in rating Capitalization on EBS. Newron Pharmaceuticals S.p.A. is #154 in rating Stock price grown in 3 years on EBS. Newron Pharmaceuticals S.p.A. is #160 in rating Net income on EBS.

Newron Pharmaceuticals S.p.A. earnings per share rating is compiled based on the results of financial statements on earnings. Earnings per share - the stock exchange characteristic of the company, which shows the share of profit reduced to 1 share. The “earnings per share” rating is growing for those companies in which, as a rule, earnings per share are also growing.

Rating Newron Pharmaceuticals S.p.A. net income - a list of companies collected by the amount of total income. Net income is calculated as the total revenue of the company, not taking into account the quantity and value of its shares. The top ranking of "Net income of the company" is usually headed by the largest and most profitable companies.

Newron Pharmaceuticals S.p.A. stocks data

Newron Pharmaceuticals S.p.A. financials